Tiamat Achieves Breakthrough in Expression of mRNA Enzyme

“Tiamat Sciences Corporation, a pioneering plant-based reagent company, proudly announces a significant milestone in the realm of mRNA enzyme production. Tiamat Sciences has successfully expressed T7 polymerase, a crucial enzyme for mRNA vaccine synthesis, within its plant system with the goal of producing the enzyme for use in mRNA production processes. This achievement marks a leap forward in the quest for more efficient, sustainable, and scalable methods for vaccine development.

Tiamat Sciences’ achievement demonstrates the efficacy of harnessing plant-based systems to produce essential reagents.

This achievement holds profound implications for the pharmaceutical industry, particularly in the context of pandemic preparedness and rapid vaccine development. The ability to produce critical enzymes like T7 polymerase in plant systems offers unparalleled flexibility, scalability, and cost-effectiveness, paving the way for the accelerated production of mRNA vaccines on a global scale.”